SCHEMBL17667676

SCHEMBL17667676

CC(C)C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)OB(O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR139 Q6DWJ6 3/20 0.58
▸ PSMB5 P28074 7/20 0.52
▸ PSMB8 P28062 6/20 0.52
▸ PSMB9 P28065 6/20 0.52
▸ PSMB6 P28072 6/20 0.52
▸ PSMB10 P40306 6/20 0.52
▸ PSMB11 A5LHX3 5/20 0.52
▸ PSMA7 O14818 5/20 0.52
▸ PSMB1 P20618 5/20 0.52
▸ PSMA1 P25786 5/20 0.52
▸ PSMA2 P25787 5/20 0.52
▸ PSMA3 P25788 5/20 0.52
▸ PSMA4 P25789 5/20 0.52
▸ PSMA5 P28066 5/20 0.52
▸ PSMB4 P28070 5/20 0.52
▸ PSMB3 P49720 5/20 0.52
▸ PSMB2 P49721 5/20 0.52
▸ PSMA6 P60900 5/20 0.52
▸ PSMA8 Q8TAA3 5/20 0.52
▸ PSMB7 Q99436 5/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10005018 0.92 GPR139 (0.59) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL10004951 0.88 PSMB5 (0.60) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL17667669 0.87 PSMB5 (0.53) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL10004915 0.87 PSMB5 (0.55) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL10005156 0.86 PSMB5 (0.71) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL21977963 0.86 PSMB5 (0.71) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL21977965 0.84 PSMB5 (0.58) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL29768798 0.84 PSMB5 (0.58) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL10004622 0.84 PSMB5 (0.58) GPR139PSMB5PSMB8PSMB9PSMB6
SCHEMBL10005024 0.83 PSMB5 (0.48) GPR139PSMB5PSMB8PSMB9PSMB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560647-B1 COMBINATION THERAPY WITH A PROTEASOME INHIBITOR AND A GALLIUM COMPLEX NIIKI PHARMA INC (US) 2016-04-13 — — EP claimed
Send feedback